PLD
56
8
SWKS
33
-10
CMG
69
-3
HCP
70
-4
LB
63
-4
NOC
40
-10
EMN
50
-2
BA
45
-3
REGN
42
-2
PCG
99
2
T
48
3
PNR
74
5
DRI
56
2
HPE
70
2
EW
32
3
PWR
71
-3
WMB
68
-2
CF
53
2
NWSA
71
-2
EFX
41
-2
PLD
56
8
SWKS
33
-10
CMG
69
-3
HCP
70
-4
LB
63
-4
NOC
40
-10
EMN
50
-2
BA
45
-3
REGN
42
-2
PCG
99
2
T
48
3
PNR
74
5
DRI
56
2
HPE
70
2
EW
32
3
PWR
71
-3
WMB
68
-2
CF
53
2
NWSA
71
-2
EFX
41
-2
Financhill
Back

Citius Oncology Quote, Financials, Valuation and Earnings

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.
Sell
1

CTOR
Citius Oncology

Last Price:
1.12
Seasonality Move:
--

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.

Citius Oncology Price Quote

$1.12
-0.10 (-8.2%)
(Updated: November 14, 2024 at 12:10 PM ET)

Citius Oncology Key Stats

Sell
1
Citius Oncology (CTOR) is a Sell
Day range:
$1.18 - $1.36
52-week range:
$0.93 - $4.42
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
74.5K
Avg. volume:
97.9K
1-year change:
0%
Market cap:
$92.6M
Revenue:
$0
EPS:
$0

How Much Does Citius Oncology Make?

Data Unavailable

Is Citius Oncology Growing As A Company?

Data Unavailable

Citius Oncology Stock Price Performance

  • Did Citius Oncology Stock Go Up Last Month?
    Citius Oncology share price went up by 20.79% last month
  • Did CTOR's Share Price Rise Over The Last Year?
    CTOR share price rose by 0% over the past 1 year

What Is Citius Oncology 52-Week High & Low?

Citius Oncology Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Citius Oncology?

Data Unavailable

Is Citius Oncology Cash Flow Positive?

Data Unavailable

Citius Oncology Return On Invested Capital

Data Unavailable

Citius Oncology Earnings Date & Stock Price

Citius Oncology Competitors

  • Who Are Citius Oncology's Competitors?
    Below is a list of companies who compete with Citius Oncology or are related in some way:
    • Citius Pharmaceuticals Inc (CTXR)
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Citius Oncology Dividend Yield

Citius Oncology Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many CTOR shares are owned by institutional investors?
    2.3K CTOR shares are owned by institutional investors
  • How many CTOR shares are owned by insiders?
    0 CTOR shares are owned by insiders